Defining anxious depression: going beyond comorbidity (Q35607283)

9 August 2017

1 reference

title

Defining anxious depression: going beyond comorbidity (English)

1 reference

9 August 2017

1 reference

Peter H Silverstone

1

1 reference

PubMed ID

14674050

9 August 2017

Erica von Studnitz

series ordinal

2

1 reference

PubMed ID

14674050

9 August 2017

language of work or name

English

0 references

publication date

1 November 2003

1 reference

Canadian Journal of Psychiatry

9 August 2017

1 reference

9 August 2017

48

1 reference

9 August 2017

10

1 reference

9 August 2017

675-680

1 reference

Cross-cultural research on depression

9 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F070674370304801006

The selective serotonin reuptake inhibitor paroxetine is effective in more generalized and in less generalized social anxiety disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370304801006

Paroxetine for social anxiety and alcohol use in dual-diagnosed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370304801006

Pharmacotherapy of social anxiety disorder at the turn of the millennium

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370304801006

Fluoxetine in social phobia: a double-blind, placebo-controlled pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370304801006

Risk factors for 12-month comorbidity of mood, anxiety, and substance use disorders: findings from the Netherlands Mental Health Survey and Incidence Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370304801006

Current Comorbidity of Psychiatric Disorders Among DSM-IV Major Depressive Disorder Patients in Psychiatric Care in the Vantaa Depression Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370304801006

Treatment resistant depression and axis I co-morbidity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370304801006

Relation between anxiety and depressive disorders in childhood and adolescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370304801006

Comorbidity of depression and anxiety disorders in later life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370304801006

Depression and anxiety in older women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370304801006

Antidepressant-Associated Mania and Psychosis Resulting in Psychiatric Admissions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370304801006

The identification and validation of distinct depressive syndromes in a population-based sample of female twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370304801006

Follow-up and family study of anxious depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370304801006

RECOGNIZING THE ANXIOUS FACE OF DEPRESSION

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370304801006

Symptomatic and syndromal anxiety and depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370304801006

Comparative effects of amitriptyline and amineptine in patients affected by anxious depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370304801006

Therapeutic efficacy of antidepressants in agitated anxious depression--a meta-analysis of moclobemide studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370304801006

A meta-analysis of the effects of venlafaxine on anxiety associated with depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370304801006

Is anxious-agitated major depression responsive to fluoxetine? A double-blind comparison with amitriptyline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370304801006

Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370304801006

Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370304801006

Fluoxetine alone in the treatment of first episode anxious-depression: an open clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370304801006

Anxiety disorders and major depression, together or apart

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674370304801006

10.1177/070674370304801006

21 January 2018

Identifiers

DOI

1 reference

9 August 2017

1 reference

PubMed ID

14674050